MedTrace Logo

BEETROOT JUICE INTAKE in POSTMENOPAUSAL HYPERTENSIVE WOMEN

NCT06584331 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2024-09-23

No results posted yet for this study

Summary

The goal of this clinical trial is to verify the hemodynamic and biomarker responses of beetroot juice intake in postmenopausal women with hypertension. The main questions it aims to answer are:

Is beetroot juice dose related to better hemodynamic responses in hypertensive postmenopausal women? Is beetroot juice dose related to better oxidative stress profile responses in hypertensive postmenopausal women?

The investigators will conduct a parallel clinical study with 10 days of intervention, in which 48 women will be randomized into 3 groups: 1) Two shots of beetroot juice intake per day (800mg of NO3-); 2) One shot of beetroot juice intake per day (400mg of NO3-); 3) placebo intake (beetroot juice without NO3-).

Conditions

Interventions

DIETARY_SUPPLEMENT

1 dose of Beetroot juice intake

The volunteers will ingest 70 ml of beetroot juice with 400 mg of nitrate every morning for 10 days

DIETARY_SUPPLEMENT

2 doses of Beetroot juice intake

This group will ingest 2 shots of 70 ml of beetroot juice with 400mg of nitrate, in each shot, for 10 days.

DIETARY_SUPPLEMENT

Placebo

In this group, the participants will receive 70ml of low-nitrate beetroot juice to consume in the morning.

Sponsors & Collaborators

  • Federal University of Uberlandia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-07
Primary Completion
2025-07-31
Completion
2028-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06584331 on ClinicalTrials.gov